favicon

T4K3.news

Ketamine Queen pleads guilty in Perry case

A plea agreement ends the trial for Sangha, closing another chapter in the Perry case.

August 18, 2025 at 08:11 PM
blur ‘Ketamine Queen’ accused of selling fatal dose to Matthew Perry agrees to plead guilty

A woman known as the Ketamine Queen agrees to plead guilty to multiple drug charges linked to Matthew Perry's death, avoiding a planned trial.

Ketamine Queen pleads guilty in Perry case

Jasveen Sangha, the fifth and final defendant in the Matthew Perry overdose case, has agreed to plead guilty to conspiracy to distribute ketamine, maintaining a drug involved premises, and related drug distribution charges. Prosecutors say she supplied ketamine to Perry through middlemen and could face up to 45 years in prison. The other four defendants have already pleaded guilty or agreed to cooperate in exchange for sentences or leniency, shaping the track of the case. A plea hearing will schedule sentencing.

Perry, the star of Friends, died on Oct 28, 2023 in Los Angeles from ketamine intoxication. Investigators said the drug was obtained through Dr. Salvador Plasencia and Sangha, with Perry buying large amounts in the weeks before his death. Messages describe Sangha’s ketamine as high quality and meant for celebrities, and investigators say the group deleted messages on the day of Perry’s death. Sangha’s North Hollywood home was raided in March 2024, leading to charges that included large quantities of methamphetamine and ketamine.

Key Takeaways

✔️
Sangha pleads guilty, closing the criminal case for the defendant group
✔️
Prosecutors cast Sangha as a central figure known as the Ketamine Queen
✔️
Several co defendants already pled guilty or agreed to cooperate
✔️
Ketamine supplied to Perry was linked to a pattern of purchases weeks before death
✔️
The case raises questions about off label ketamine use in medical treatment for depression
✔️
The plea could lead to lengthy prison time and signals strict penalties for illegal drug distribution
✔️
Ongoing investigations may affect related cases or policy discussions

"fame does not shield anyone from consequences"

Editorial reflection on accountability in high profile cases

"a plea ends the trial but leaves questions"

Commentary on the legal process following a plea

"the case shows how off label medical use can intersect with illegal markets"

Observation about medical practice and crime

"the public will watch how the system handles both doctors and dealers"

Public interest in legal accountability

The case illustrates how celebrity status can intersect with illegal drug networks and how prosecutors pursue dealers even as medical professionals are scrutinized for off label use. It also highlights how plea deals shift the legal focus from a trial to accountability and deterrence. As the legal process unfolds, the debate over off label ketamine use in depression remains unresolved and the line between care and crime stays murky.

Highlights

  • fame does not shield anyone from consequences
  • the line between treatment and trafficking blurred here
  • justice moves slowly but it arrives
  • money and drugs wear a dangerous mask

Public backlash risk in Perry case

The plea and the ongoing investigation could provoke public scrutiny and debate about medical treatment, addiction, and accountability for public figures.

The legal process will continue to test how care, crime and accountability intersect in crowded courtroom and public discussion.

Enjoyed this? Let your friends know!

Related News